Streetbeat News

Equity Actions

VRAX

Virax Biolabs Group shares declined following the announcement of a $5 million registered direct offering, selling 1,108,892 shares at $4.50 each.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:07 pm

REVB

Revelation Biosciences has entered into an agreement for the immediate exercise of 2.55 million warrants at $1.50 per share, with the closing expected on August 22, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:05 pm

OBLG

Oblong, Inc. (NASDAQ:OBLG) announced a 1-for-40 reverse stock split, effective August 23, 2024. The split-adjusted shares will begin trading on August 26, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 12:02 pm

SCHW

Charles Schwab shares declined after TD Bank sold 40.50 million shares, reducing its ownership from 12.3% to 10.1%.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 11:25 am

VRAX

Virax Biolabs has announced a $5 million registered direct offering, selling 1,108,892 common shares at $4.50 per share.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2024 | 7:21 am

SCHW

Charles Schwab shares declined after TD Bank sold 40.50 million shares, reducing its ownership from 12.3% to 10.1%.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 9:25 pm

SCHW

TD

TD Bank has sold 40.50 million shares of Charles Schwab, reducing its ownership from 12.3% to 10.1%. TD has agreed not to sell more shares for 45 days, with some exceptions, and has no current plans to divest further.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 9:14 pm

AEON

Aeon Biopharma has filed with the SEC for a Class A common stock offering, aiming to raise up to $50 million.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 8:30 pm

ALVO

Alvotech has filed for an offering of up to 1.8 million shares by a selling shareholder, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 8:28 pm

DSS

Document Security Systems, Inc. (DSS) announced that CEO Frank Heuszel will step down, and Jason Grady has been elected as the interim CEO, as per an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 8:27 pm